NEOEN SA (NEOEN.PA)

FR0011675362 - Common Stock

39.75  +0.01 (+0.03%)

Fundamental Rating

4

Taking everything into account, NEOEN scores 4 out of 10 in our fundamental rating. NEOEN was compared to 21 industry peers in the Independent Power and Renewable Electricity Producers industry. NEOEN has a medium profitability rating, but doesn't score so well on its financial health evaluation. NEOEN is quite expensive at the moment. It does show a decent growth rate.



6

1. Profitability

1.1 Basic Checks

In the past year NEOEN was profitable.
NEOEN had a positive operating cash flow in the past year.
NEOEN had positive earnings in each of the past 5 years.
Each year in the past 5 years NEOEN had a positive operating cash flow.

1.2 Ratios

NEOEN has a Return On Assets (1.15%) which is in line with its industry peers.
NEOEN's Return On Equity of 3.31% is in line compared to the rest of the industry. NEOEN outperforms 55.56% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.05%, NEOEN is doing worse than 61.11% of the companies in the same industry.
NEOEN had an Average Return On Invested Capital over the past 3 years of 2.78%. This is in line with the industry average of 3.72%.
Industry RankSector Rank
ROA 1.15%
ROE 3.31%
ROIC 2.05%
ROA(3y)1.19%
ROA(5y)0.95%
ROE(3y)3.69%
ROE(5y)3.42%
ROIC(3y)2.78%
ROIC(5y)2.85%

1.3 Margins

NEOEN has a Profit Margin of 18.03%. This is in the better half of the industry: NEOEN outperforms 72.22% of its industry peers.
In the last couple of years the Profit Margin of NEOEN has grown nicely.
With an excellent Operating Margin value of 45.64%, NEOEN belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
In the last couple of years the Operating Margin of NEOEN has remained more or less at the same level.
NEOEN has a better Gross Margin (99.34%) than 100.00% of its industry peers.
NEOEN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 45.64%
PM (TTM) 18.03%
GM 99.34%
OM growth 3Y-4.85%
OM growth 5Y-0.47%
PM growth 3Y179.97%
PM growth 5Y36.74%
GM growth 3Y-0.63%
GM growth 5Y-0.15%

2

2. Health

2.1 Basic Checks

NEOEN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for NEOEN has been increased compared to 1 year ago.
The number of shares outstanding for NEOEN has been increased compared to 5 years ago.
NEOEN has a better debt/assets ratio than last year.

2.2 Solvency

NEOEN has an Altman-Z score of 0.97. This is a bad value and indicates that NEOEN is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.97, NEOEN is in line with its industry, outperforming 55.56% of the companies in the same industry.
NEOEN has a Debt/Equity ratio of 1.42. This is a high value indicating a heavy dependency on external financing.
NEOEN's Debt to Equity ratio of 1.42 is on the low side compared to the rest of the industry. NEOEN is outperformed by 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.42
Debt/FCF N/A
Altman-Z 0.97
ROIC/WACC0.36
WACC5.69%

2.3 Liquidity

A Current Ratio of 1.18 indicates that NEOEN should not have too much problems paying its short term obligations.
The Current ratio of NEOEN (1.18) is worse than 61.11% of its industry peers.
NEOEN has a Quick Ratio of 1.17. This is a normal value and indicates that NEOEN is financially healthy and should not expect problems in meeting its short term obligations.
NEOEN has a Quick ratio of 1.17. This is comparable to the rest of the industry: NEOEN outperforms 44.44% of its industry peers.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 1.17

6

3. Growth

3.1 Past

The earnings per share for NEOEN have decreased strongly by -44.71% in the last year.
NEOEN shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 51.66% yearly.
The Revenue has decreased by -9.55% in the past year.
The Revenue has been growing by 20.43% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-44.71%
EPS 3Y196.53%
EPS 5Y51.66%
EPS Q2Q%-68.8%
Revenue 1Y (TTM)-9.55%
Revenue growth 3Y20.62%
Revenue growth 5Y20.43%
Sales Q2Q%-7.69%

3.2 Future

Based on estimates for the next years, NEOEN will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.54% on average per year.
NEOEN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.78% yearly.
EPS Next Y-10.01%
EPS Next 2Y17.27%
EPS Next 3Y19.44%
EPS Next 5Y16.54%
Revenue Next Year10.08%
Revenue Next 2Y20.4%
Revenue Next 3Y19.62%
Revenue Next 5Y19.78%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

NEOEN is valuated quite expensively with a Price/Earnings ratio of 66.25.
Based on the Price/Earnings ratio, NEOEN is valued a bit more expensive than 72.22% of the companies in the same industry.
NEOEN's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.40.
A Price/Forward Earnings ratio of 42.49 indicates a quite expensive valuation of NEOEN.
Based on the Price/Forward Earnings ratio, NEOEN is valued a bit more expensive than 66.67% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of NEOEN to the average of the S&P500 Index (23.67), we can say NEOEN is valued expensively.
Industry RankSector Rank
PE 66.25
Fwd PE 42.49

4.2 Price Multiples

NEOEN's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 23.19

4.3 Compensation for Growth

The decent profitability rating of NEOEN may justify a higher PE ratio.
A more expensive valuation may be justified as NEOEN's earnings are expected to grow with 19.44% in the coming years.
PEG (NY)N/A
PEG (5Y)1.28
EPS Next 2Y17.27%
EPS Next 3Y19.44%

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.38%, NEOEN is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.72, NEOEN has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.33, NEOEN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.38%

5.2 History

The dividend of NEOEN decreases each year by -9.76%.
Dividend Growth(5Y)-9.76%
Div Incr Years2
Div Non Decr Years2

5.3 Sustainability

NEOEN pays out 6.39% of its income as dividend. This is a sustainable payout ratio.
DP6.39%
EPS Next 2Y17.27%
EPS Next 3Y19.44%

NEOEN SA

EPA:NEOEN (1/6/2025, 7:00:00 PM)

39.75

+0.01 (+0.03%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)11-05 2024-11-05
Earnings (Next)N/A N/A
Inst Owners32.68%
Inst Owner ChangeN/A
Ins Owners0.6%
Ins Owner ChangeN/A
Market Cap6.08B
Analysts50.67
Price Target38.87 (-2.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.38%
Dividend Growth(5Y)-9.76%
DP6.39%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.94%
PT rev (3m)2.16%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.42%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.63%
Valuation
Industry RankSector Rank
PE 66.25
Fwd PE 42.49
P/S 12.08
P/FCF N/A
P/OCF 17.01
P/B 2.22
P/tB 2.61
EV/EBITDA 23.19
EPS(TTM)0.6
EY1.51%
EPS(NY)0.94
Fwd EY2.35%
FCF(TTM)-6.63
FCFYN/A
OCF(TTM)2.34
OCFY5.88%
SpS3.29
BVpS17.91
TBVpS15.21
PEG (NY)N/A
PEG (5Y)1.28
Profitability
Industry RankSector Rank
ROA 1.15%
ROE 3.31%
ROCE 3.21%
ROIC 2.05%
ROICexc 2.21%
ROICexgc 2.36%
OM 45.64%
PM (TTM) 18.03%
GM 99.34%
FCFM N/A
ROA(3y)1.19%
ROA(5y)0.95%
ROE(3y)3.69%
ROE(5y)3.42%
ROIC(3y)2.78%
ROIC(5y)2.85%
ROICexc(3y)3.18%
ROICexc(5y)3.27%
ROICexgc(3y)3.41%
ROICexgc(5y)3.51%
ROCE(3y)4.34%
ROCE(5y)4.45%
ROICexcg growth 3Y-9.89%
ROICexcg growth 5Y-5.73%
ROICexc growth 3Y-9.46%
ROICexc growth 5Y-5.55%
OM growth 3Y-4.85%
OM growth 5Y-0.47%
PM growth 3Y179.97%
PM growth 5Y36.74%
GM growth 3Y-0.63%
GM growth 5Y-0.15%
F-Score5
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 1.42
Debt/FCF N/A
Debt/EBITDA 9.22
Cap/Depr 709.21%
Cap/Sales 272.35%
Interest Coverage 1.77
Cash Conversion 84.46%
Profit Quality N/A
Current Ratio 1.18
Quick Ratio 1.17
Altman-Z 0.97
F-Score5
WACC5.69%
ROIC/WACC0.36
Cap/Depr(3y)611.79%
Cap/Depr(5y)644.77%
Cap/Sales(3y)215.49%
Cap/Sales(5y)225.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-44.71%
EPS 3Y196.53%
EPS 5Y51.66%
EPS Q2Q%-68.8%
EPS Next Y-10.01%
EPS Next 2Y17.27%
EPS Next 3Y19.44%
EPS Next 5Y16.54%
Revenue 1Y (TTM)-9.55%
Revenue growth 3Y20.62%
Revenue growth 5Y20.43%
Sales Q2Q%-7.69%
Revenue Next Year10.08%
Revenue Next 2Y20.4%
Revenue Next 3Y19.62%
Revenue Next 5Y19.78%
EBIT growth 1Y-40.1%
EBIT growth 3Y14.77%
EBIT growth 5Y19.86%
EBIT Next Year83.13%
EBIT Next 3Y40.79%
EBIT Next 5Y28.98%
FCF growth 1Y-46.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15.98%
OCF growth 3Y13.46%
OCF growth 5Y15.72%